2024-11-20 10:30:28
IASO Bio and Innovent Jointly Announce the NMPA Acceptance of the New Drug Application for Equecabtagene Autoleucel for the Treatment of Relapsed and/or Refractory Multiple Myeloma
Health/ 2023-07-22
IASO Bio and Innovent Jointly Announce t...

SHANGHAI,NANJING,China,and SAN JOSE,Calif.,June 2,2022--IASO Biotherapeutics ("IASO Bio"),a clinical-stage biopharmaceutical compa...

Sanyou Super-Trillion Innovative Antibody Drug Discovery Platform Announced - World Premiere
Health/ 2023-07-22
Sanyou Super-Trillion Innovative Antibod...

SHANGHAI,June 3,2022-- Sanyou Biopharmaceuticals officially launched STAL (Super-Trillion Antibody Libraries) on June 3,2022,which is a supe...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release